Table 6.
Target | Significance |
---|---|
Eukaryotic PRODH | Cancer drug design target |
PRODH complexed with ubiquinone | No structure of any PRODH or PutA complexed with a bona fide biological quinone; provides information about membrane association. |
GSALDH complexed with P5C/GSAL | Addresses the question of whether GSALDH directly binds GSAL or converts P5C to GSAL in the active site |
1C PutA | The most complex of all PutAs; provides insight into the structural basis of transcriptional regulation and functional switching |
3B PutA dimer | Potentially unique dimer induced by ligand binding |
PutA with P5C/GSAL in the tunnel | Determine the identity of the channeled species; reveal the roles of tunnel residues in facilitating channeling |
PRODH-GSALDH protein–protein complex | Structural basis of PRODH-GSALDH intermolecular substrate channeling |
GSAL, l-glutamate-γ-semialdehyde.